Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2026-02-23 @ 8:31 PM
Study NCT ID:
NCT00514293
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2007-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Raghu Nandan, M.D., Inc
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CDR0000561066
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Raghu Nandan
Old Organization:
R. Nandan M.D. Incorporated